Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 9/2018

27.04.2018 | Assisted Reproduction Technologies

Low estradiol responses in oocyte donors undergoing gonadotropin stimulation do not influence clinical outcomes

verfasst von: Katherine L. Palmerola, Briana J. Rudick, Rogerio A. Lobo

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To examine the effect of low and very low estradiol responses in oocyte donors receiving gonadotropins on clinical outcomes of donor in vitro fertilization (IVF) cycles and to identify possible mechanisms responsible for low estradiol response.

Methods

This is a retrospective cohort study of oocyte donors undergoing antagonist IVF cycles with progression to oocyte retrieval between January 2010 and December 2016 at a single urban academic fertility center. Oocyte yield, fertilization rate, blastocyst rate, percentage of normal embryos on preimplantation genetic screening (PGS), pregnancy outcomes, and follicular fluid steroid profiles were compared between donors with normal estradiol response and those with low estradiol response.

Results

Three hundred sixty-six antagonist oocyte donor IVF cycles were identified: 42 cycles had a normal estradiol response (NE2), defined as peak serum estradiol (E2) of over 200 pg/mL per retrieved oocyte; 140 cycles had an intermediate estradiol response (iE2), defined as peak serum E2 between 100 and 200 pg/mL per retrieved oocyte; 110 cycles had a low estradiol response (LE2), defined as peak serum E2 between 50 and 100 pg/mL per retrieved oocyte; and 74 cycles had a very low estradiol response (vLE2), defined as peak serum E2 less than 50 pg/mL per retrieved oocyte. LE2 cycles resulted in a greater number of mature oocytes (22.4 vs. 13.6, p < 0.017), and fertilizations versus NE2 donors (18.5 vs. 10.7, p < 0.017), although the number of transferred or cryopreserved blastocysts were similar between groups (8.6, 6.9 vs. 4.8, p = 0.095, p = 1). The percentage of chromosomally normal embryos after PGS was similar between LE2, vLE2, and NE2 cycles (66.4, 71.8 vs. 63.1%, p = 0.99, p = 1). Pregnancy outcomes were similar between LE2, vLE2, and NE2 cycles. Serum AMH obtained on the day of peak E2 was similar to baseline serum AMH and did not differ between LE2 versus NE2 cycles. Follicular fluid E2 levels paralleled serum E2 levels and were lower in LE2 cycles versus NE2 cycles.

Conclusion

The prevalence of very low E2 responses in donors appears to be high (20.2%). In contrast to autologous IVF cycles, LE2 does not portend poor outcomes in oocyte donors.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Fritz M, Speroff L. Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2011. Fritz M, Speroff L. Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2011.
2.
Zurück zum Zitat Mittal S, Gupta P, Malhotra N, Singh N. Serum estradiol as a predictor of success of in vitro fertilization. J Obstet Gynaecol India. 2014;64:124–9.CrossRefPubMed Mittal S, Gupta P, Malhotra N, Singh N. Serum estradiol as a predictor of success of in vitro fertilization. J Obstet Gynaecol India. 2014;64:124–9.CrossRefPubMed
3.
Zurück zum Zitat Hu X, Luo Y, Huang K, Li Y, Xu Y, Zhou C, et al. New perspectives on criteria for the determination of HCG trigger timing in GnRH antagonist cycles. Medicine. 2016;95:e3691.CrossRefPubMedPubMedCentral Hu X, Luo Y, Huang K, Li Y, Xu Y, Zhou C, et al. New perspectives on criteria for the determination of HCG trigger timing in GnRH antagonist cycles. Medicine. 2016;95:e3691.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2014 assisted reproductive technology national summary report: Atlanta; 2016. Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2014 assisted reproductive technology national summary report: Atlanta; 2016.
5.
Zurück zum Zitat Orvieto R, Zohav E, Scharf S, et al. The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization. Gynecol Endocrinol. 2007;23:72–5.CrossRefPubMed Orvieto R, Zohav E, Scharf S, et al. The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization. Gynecol Endocrinol. 2007;23:72–5.CrossRefPubMed
6.
Zurück zum Zitat Yang J, Chen H, Lien Y, Chen S, Ho H, Yang Y. Elevated E2: oocyte ratio in women undergoing IVF and tubal ET. Correlation with a decrease in the implantation rate. J Reprod Med. 2001;46:434–8.PubMed Yang J, Chen H, Lien Y, Chen S, Ho H, Yang Y. Elevated E2: oocyte ratio in women undergoing IVF and tubal ET. Correlation with a decrease in the implantation rate. J Reprod Med. 2001;46:434–8.PubMed
7.
Zurück zum Zitat Vaughan DA, Harrity C, Sills ES, Mocanu EV. Serum estradiol:oocyte ratio as a predictor of reproductive outcome: an analysis of data from >9000 IVF cycles in the Republic of Ireland. J Assist Reprod Genet. 2016;33:481–8.CrossRefPubMedPubMedCentral Vaughan DA, Harrity C, Sills ES, Mocanu EV. Serum estradiol:oocyte ratio as a predictor of reproductive outcome: an analysis of data from >9000 IVF cycles in the Republic of Ireland. J Assist Reprod Genet. 2016;33:481–8.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Haas J, Baum M, Meridor K, Hershko-Klement A, Elizur S, Hourvitz A, et al. Is severe OHSS associated with adverse pregnancy outcomes? Evidence from a case-control study. Reprod BioMed Online. 2014;29:216–21.CrossRefPubMed Haas J, Baum M, Meridor K, Hershko-Klement A, Elizur S, Hourvitz A, et al. Is severe OHSS associated with adverse pregnancy outcomes? Evidence from a case-control study. Reprod BioMed Online. 2014;29:216–21.CrossRefPubMed
9.
Zurück zum Zitat Raziel A, Friedler S, Schachter M, Strassburger D, Mordechai E, Ron-El R. Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome. Hum Reprod. 2002;17:107–10.CrossRefPubMed Raziel A, Friedler S, Schachter M, Strassburger D, Mordechai E, Ron-El R. Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome. Hum Reprod. 2002;17:107–10.CrossRefPubMed
10.
Zurück zum Zitat Karlsson MO, Wade JR, Loumaye E, Munafo A. The population pharmacokinetics of recombinant- and urinary-human follicle stimulating hormone in women. Br J Clin Pharmacol. 1998;45:13–20.CrossRefPubMedPubMedCentral Karlsson MO, Wade JR, Loumaye E, Munafo A. The population pharmacokinetics of recombinant- and urinary-human follicle stimulating hormone in women. Br J Clin Pharmacol. 1998;45:13–20.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Kim J, Lee J, Chang H, Jee B, Suh C, Kim S. Anti-Mullerian hormone levels in the follicular fluid of the preovulatory follicle: a predictor for oocyte fertilization and quality of embryo. J Korean Med Sci. 2014;29:1266–70.CrossRefPubMedPubMedCentral Kim J, Lee J, Chang H, Jee B, Suh C, Kim S. Anti-Mullerian hormone levels in the follicular fluid of the preovulatory follicle: a predictor for oocyte fertilization and quality of embryo. J Korean Med Sci. 2014;29:1266–70.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Seifer D, Maclaughlin D. Mullerian inhibiting substance is an ovarian growth factor of emerging clinical significance. Fertil Steril. 2007;88:539–46.CrossRefPubMed Seifer D, Maclaughlin D. Mullerian inhibiting substance is an ovarian growth factor of emerging clinical significance. Fertil Steril. 2007;88:539–46.CrossRefPubMed
13.
Zurück zum Zitat Vet AD, Laven J, Jong FD, Themmen A, Fauser B. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77:357–62.CrossRefPubMed Vet AD, Laven J, Jong FD, Themmen A, Fauser B. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77:357–62.CrossRefPubMed
14.
Zurück zum Zitat Seifer D, MacLaughlin D, Christian B, Feng B, Shelder R. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril. 2002;77:468–71.CrossRefPubMed Seifer D, MacLaughlin D, Christian B, Feng B, Shelder R. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril. 2002;77:468–71.CrossRefPubMed
15.
Zurück zum Zitat van Rooij IA, Broekmans FJ, te Velde ER, et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002;17:3065–71.CrossRefPubMed van Rooij IA, Broekmans FJ, te Velde ER, et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002;17:3065–71.CrossRefPubMed
16.
Zurück zum Zitat Lee J, Kim S, Kim S, et al. Anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction. Hum Reprod. 2010;25:2597–604.CrossRefPubMed Lee J, Kim S, Kim S, et al. Anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction. Hum Reprod. 2010;25:2597–604.CrossRefPubMed
17.
Zurück zum Zitat Silberstein T, MacLaughlin D, Shai I, et al. Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Hum Reprod. 2006;21:159–63.CrossRefPubMed Silberstein T, MacLaughlin D, Shai I, et al. Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Hum Reprod. 2006;21:159–63.CrossRefPubMed
18.
Zurück zum Zitat Takahashi C, Fujito A, Kazuka M, Sugiyama R, Ito H, Isaka K. Anti-Mullerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization. Fertil Steril. 2008;89:586–91.CrossRefPubMed Takahashi C, Fujito A, Kazuka M, Sugiyama R, Ito H, Isaka K. Anti-Mullerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization. Fertil Steril. 2008;89:586–91.CrossRefPubMed
19.
Zurück zum Zitat Fanchin R, Lozano DM, Frydman N, et al. Anti-Mullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization. J Clin Endocrinol Metab. 2007;92:1796–802.CrossRefPubMed Fanchin R, Lozano DM, Frydman N, et al. Anti-Mullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization. J Clin Endocrinol Metab. 2007;92:1796–802.CrossRefPubMed
20.
Zurück zum Zitat Li L, Ferin M, Sauer M, Lobo R. Dehydroepiandrosterone in follicular fluid is produced locally, and levels correlate negatively with in vitro fertilization outcomes. Fertil Steril. 2011;95:1830–2.CrossRefPubMed Li L, Ferin M, Sauer M, Lobo R. Dehydroepiandrosterone in follicular fluid is produced locally, and levels correlate negatively with in vitro fertilization outcomes. Fertil Steril. 2011;95:1830–2.CrossRefPubMed
21.
Zurück zum Zitat Li L, Ferin M, Sauer M, Lobo R. Serum and follicular fluid ghrelin levels negatively reflect human oocyte quality and in vitro embryo development. Fertil Steril. 2011;96:1116–20.CrossRefPubMed Li L, Ferin M, Sauer M, Lobo R. Serum and follicular fluid ghrelin levels negatively reflect human oocyte quality and in vitro embryo development. Fertil Steril. 2011;96:1116–20.CrossRefPubMed
22.
Zurück zum Zitat Foong S, Abbott D, Lesnick T, Session D, Walker D, Dumesic D. Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating hormone. Fertil Steril. 2005;83:1377–83.CrossRefPubMed Foong S, Abbott D, Lesnick T, Session D, Walker D, Dumesic D. Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating hormone. Fertil Steril. 2005;83:1377–83.CrossRefPubMed
23.
Zurück zum Zitat de los Santos MJ, Garcia-Laez V, Beltran-Torregrosa D, et al. Hormonal and molecular characterization of follicular fluid, cumulus cells and oocytes from pre-ovulatory follicles in stimulated and unstimulated cycles. Hum Reprod. 2012;27:1596–605.CrossRefPubMed de los Santos MJ, Garcia-Laez V, Beltran-Torregrosa D, et al. Hormonal and molecular characterization of follicular fluid, cumulus cells and oocytes from pre-ovulatory follicles in stimulated and unstimulated cycles. Hum Reprod. 2012;27:1596–605.CrossRefPubMed
24.
Zurück zum Zitat Rodgers RJ, Reid GD, Koch J, Deans R, Ledger WL, Friedlander M, et al. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review. Hum Reprod. 2017;32:1033–45.CrossRefPubMed Rodgers RJ, Reid GD, Koch J, Deans R, Ledger WL, Friedlander M, et al. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review. Hum Reprod. 2017;32:1033–45.CrossRefPubMed
25.
Zurück zum Zitat Bianchi PH, Gouveia GR, Costa EM, et al. Successful live birth in a woman with 17alpha-hydroxylase deficiency through IVF frozen-thawed embryo transfer. J Clin Endocrinol Metab. 2016;101:345–8.CrossRefPubMed Bianchi PH, Gouveia GR, Costa EM, et al. Successful live birth in a woman with 17alpha-hydroxylase deficiency through IVF frozen-thawed embryo transfer. J Clin Endocrinol Metab. 2016;101:345–8.CrossRefPubMed
26.
Zurück zum Zitat Kitajima M, Miura K, Inoue T, et al. Two consecutive successful live birth in woman with 17alpha hydroxylase deficiency by frozen-thaw embryo transfer under hormone replacement endometrium preparation. Gynecol Endocrinol. 2017;34:1–4. Kitajima M, Miura K, Inoue T, et al. Two consecutive successful live birth in woman with 17alpha hydroxylase deficiency by frozen-thaw embryo transfer under hormone replacement endometrium preparation. Gynecol Endocrinol. 2017;34:1–4.
Metadaten
Titel
Low estradiol responses in oocyte donors undergoing gonadotropin stimulation do not influence clinical outcomes
verfasst von
Katherine L. Palmerola
Briana J. Rudick
Rogerio A. Lobo
Publikationsdatum
27.04.2018
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 9/2018
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-018-1192-7

Weitere Artikel der Ausgabe 9/2018

Journal of Assisted Reproduction and Genetics 9/2018 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.